{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:49:12Z","timestamp":1773701352362,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2026,3,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic\ndisease. Increasing evidence suggests that persistent inflammation and autoimmune mechanisms\nplay a critical role in its pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>T2DM was induced in rabbits through a combination of a high-sugar, high-fat diet and\nstreptozotocin (STZ) administration. The study included three groups: control, T2DM, and T2DM\n+ autologous T cell immunotherapy (ATIM). Individualized ATIM was prepared by heat shock\ntreatment of peripheral blood after erythrocyte removal. Rabbits in the ATIM group received\nintradermal injections of 0.36 mL ATIM in the thigh every two days. Blood glucose, glycated\nserum protein (GSP), glycogen synthase (GS), glycogen synthase kinase-3\u03b2 (GSK3\u03b2), T cell\nsubsets, interleukin-10 (IL-10), and interferon-gamma (IFN-\u03b3) levels were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>ATIM treatment reduced blood glucose and GSP levels, with a trend toward improved\nglucose tolerance. Compared with the T2DM group, ATIM-treated rabbits exhibited more\npreserved liver morphology and increased GS expression. The ratio of phosphorylated GSK3\u03b2 to\ntotal GSK3\u03b2 was decreased. Immunologically, ATIM increased the proportion of CD4+ T cells,\ndecreased IFN-\u03b3 levels, and increased IL-10 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>ATIM enhanced GS expression, promoted CD4+ T cell responses, and suppressed\npro-inflammatory cytokines in T2DM rabbits, potentially contributing to improved blood glucose\ncontrol and protection of islet function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>result:<\/jats:title>\n                    <jats:p>ATIM can reduce the blood glucose and GSP levels, and increase the expression of GS in T2DM rabbits. After ATIM treatment, the proportion of CD4+ T cells was higher, the level of IFN-\u03b3 was decreased, and the level of IL-10 was increased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings suggest that ATIM ameliorates T2DM through synergistic regulation\nof metabolic pathways and immune balance, supporting its potential as a therapeutic approach\ntargeting both metabolic and immune dysfunction in T2DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010398198251129103628","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:39:49Z","timestamp":1772786389000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Autologous Immunotherapy on Islet Metabolism and T Cell Immunity in Type 2 Diabetic Rabbits"],"prefix":"10.2174","volume":"27","author":[{"given":"Zhimei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of the University of South China, Hengyang, Hunan, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of the University of South China, Hengyang, Hunan, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihua","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of the University of South China, Hengyang, Hunan, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenglei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shenzhen Meidu Boya Co., Ltd, Shenzhen, Guangdong, 518000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of the University of South China, Hengyang, Hunan, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second Affiliated Hospital of the University of South China, Hengyang, Hunan, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010398198251129103628","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/250429\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010398198251129103628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:39:54Z","timestamp":1772786394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/250429\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010398198251129103628","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}